MedTrace Logo

Tranexamic Acid in Major Vascular Surgery

NCT02335359 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-05-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether tranexamic acid is effective in reducing intraoperative blood loss and necessity for haemotransfusion in patients undergoing open abdominal aortic aneurysm repair

Conditions

  • Blood Loss, Surgical

Interventions

DRUG

tranexamic acid diluted in 100 ml of saline solution (loading dose)

DRUG

tranexamic acid undiluted (continous infusion)

DRUG

Placebo

Saline

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-04
Primary Completion
2017-10-30
Completion
2018-10-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335359 on ClinicalTrials.gov